1-CYCLOHEXANEACETONITRILE – (4435-14-7)

Phillyrin, phyllyrin, UNII-VE9P4964MG, VE9P4964MG, PHILLYRIN [MI], PHILLYROSIDE, (+)-, (2S, 3R, 4S, 5S, 6R)-2-[4-[(3R, 3aR, 6S, 6aR)-3-(3, 4-dimethoxyphenyl)-1, 3, 3a, 4, 6, 6a-hexahydrofuro[3, 4-c]furan-6-yl]-2-methoxyphenoxy]-6-(hydroxymethyl)oxane-3, 4, 5-triol, DTXSID40197589, 4-(4-(3, 4-Dimethoxyphenyl)tetrahydro-1H, 3H-furo(3, 4-c)furan-1-yl)-2-methoxyphenyl, (1S-(1alpha, 3aalpha, 4beta, 6aalpha))-beta-D-glucopyranoside, .BETA.-D-GLUCOPYRANOSIDE, 4-((1S, 3AR, 4R, 6AR)-4-(3, 4-DIMETHOXYPHENYL)TETRAHYDRO-1H, 3H-FURO(3, 4-C)FURAN-1-YL)-2-METHOXYPHENYL, 4-((1S, 3AR, 4R, 6AR))-4-(4-(3, 4-DIMETHOXYPHENYL)TETRAHYDRO-1H, 3H-FURO(3, 4-C)FURAN-1-YL)-2-METHOXYPHENYL-.BETA.-D-GLUCOPYRANOSIDE, beta-D-Glucopyranoside, 4-(4-(3, 4-dimethoxyphenyl)tetrahydro-1H, 3H-furo(3, 4-c)furan-1-yl)-2-methoxyphenyl, (1S-(1alpha, 3aalpha, 4beta, 6aalpha))-, Phillyroside, (2S, 3R, 4S, 5S, 6R)-2-(4-((3R, 3aR, 6S, 6aR)-3-(3, 4-dimethoxyphenyl)-1, 3, 3a, 4, 6, 6a-hexahydrofuro(3, 4-c)furan-6-yl)-2-methoxyphenoxy)-6-(hydroxymethyl)oxane-3, 4, 5-triol, (2S, 3R, 4S, 5S, 6R)-2-(4-((3S, 3aR, 6R, 6aR)-3-(3, 4-dimethoxyphenyl)-1, 3, 3a, 4, 6, 6a-hexahydrofuro(3, 4-c)furan-6-yl)-2-methoxyphenoxy)-6-(hydroxymethyl)oxane-3, 4, 5-triol, (2S, 3R, 4S, 5S, 6R)-2-[4-[(3S, 3aR, 6R, 6aR)-3-(3, 4-dimethoxyphenyl)-1, 3, 3a, 4, 6, 6a-hexahydrofuro[3, 4-c]furan-6-yl]-2-methoxyphenoxy]-6-(hydroxymethyl)oxane-3, 4, 5-triol, Phillyrin (Standard), Phillygenin-O-glucoside, SCHEMBL710957, Phillyrin, >=98% (HPLC), CHEBI:80888, HY-N0482R, DTXCID50120080, HY-N0482, s3926, AKOS037514776, CCG-269935, beta-D-Glucopyranoside, 4-((1S, 3aR, 4R, 6aR)-4-(3, 4-dimethoxyphenyl)tetrahydro-1H, 3H-furo(3, 4-c)furan-1-yl)-2-methoxyphenyl, 1ST000538, CS-0009002, C17048, Q27151384, 4-((1S, 3AR, 4R, 6AR))-4-(4-(3, 4-DIMETHOXYPHENYL)TETRAHYDRO-1H, 3H-FURO(3, 4-C)FURAN-1-YL)-2-METHOXYPHENYL-BETA-D-GLUCOPYRANOSIDE